HPV Vaccine, Pharma Lobby Domination of Public Health Policy

Universal Health Organization press conference at Mumbai on 23rd April, 2025.
Government’s HPV vaccine Campaign - Proof of Pharma lobby dominating
our public health policy. Dr Maya Valecha
HPV vaccine at present is the most glaring example of public health policy being completely
hijacked by pharma companies. None of the major criteria, Need, Safety and effectivity,
cost-benefit ratio is fulfilled for this vaccine.
Preventing Cervical Cancer is easy and known because the causative factors are multiple
pregnancy, malnutrition, unhygienic conditions, smoking, oral contraceptives. For last
30years CC is decreasing in India at 1.8% rate because of improved socioeconomic
conditions alone.
HPV causing CC is not completely true. 95% of the time infection with even abnormal cells
gets resolved on its own. 5 to 17% of CC don’t show presence of HPV, and 7.5 t0 17 %
women with HPV don’t get CC.
That the vaccine will prevent CC is not guaranteed. A critical appraisal of phase 2 and phase
3 Efficacy Trials at New Castle University and Queen Mary University showed that these
claims are overestimated. It may not prevent even infection.
Cervavac Trial shows 1% severe side-effects, very high for any vaccine. Premature ovarian
Failure causing infertility is a known side-effect with Aluminum in it. Autoimmune disorders,
paralysis, blindness are also reported.
A paper from Sweden showed increased CC in vaccinated.
For an incidence of 14.7 per one lac(0.0147%) at the age of 55-59 years, to vaccinate all
girls at 9-15 years of age, which would cost 27200 crores by 2025 and 8480 crores every
year, better thing would be to use that money for nutrition and hygiene for those girls.
This pharma-politician-few career scientists’ nexus is bleeding our public money and
harming our health. Pneumonia vaccine, Rotavac, vaccine for Japanese Encephalitis and Covid Vaccine are other examples. Getting rid of private ownership in this vital field is the solution.